Regarding type 1 diabetes mellitus, which one statement is correct: Regarding type 1 diabetes mellitus, which one statement is correct: a. Most commonly.

Slides:



Advertisements
Similar presentations
TIME TO ACT Type 2 diabetes, the metabolic syndrome and cardiovascular disease in Europe CONTENTS Section One: Background to type 2 diabetes, the metabolic.
Advertisements

Adult Medical-Surgical Nursing Endocrine Module: DM Footcare and Patient Teaching Plan.
Long-term Complications of Type 2 Diabetes
Chapter 33 Diabetes Mellitus and the Metabolic Syndrome
Disturbances of carbohydrate metabolism. Diabetes mellitus. The State Education Institution of Higher Professional Training The First Sechenov Moscow State.
Diabetes Mellitus Pathology and complications By Dr. Abdelaty Shawky Assistant professor of pathology.
DIABETES MELLTIUS Dr. Ayisha Qureshi Assistant Professor MBBS, MPhil.
Pancreas & diabetes Željka Kušter Mentor: A. Žmegač Horvat.
Diabetes Claire Nowlan Nov 28, Comparison of type 1 and 2 diabetes Type 1 10% of diabetics Age of onset – young Severe Requires insulin Normal build.
Diabetes mellitus complications & morphology. Complications of diabetes  In type 1 &2 diabetes  Variable onset, severity,organs of involvement  Macrovascular.
Diabetes Mellitus.
The Pancreas and Diabetes Mellitus
Metabolic complications of Diabetes Mellitus
Diabetes and Aging MCB 135K Laura Epstein 4/14/06.
ENDOCRINE PANCREAS.  Diabetes Mellitus  Islet Cell tumors.
Dr Emma Hodgkins, FY1.  Globally 285 million people currently have diabetes, which is estimated to double by  UK prevalence 4.5% (5.5% in England)
Complications of Diabetes Mellitus Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health.
What is Diabetes?.
Absorptive (fed) state
Diabetes mellitus.
Adult Medical-Surgical Nursing
Diabetes Mellitus Diabetes Mellitus is a group of metabolic diseases characterized by elevated levels of glucose in blood (hyperglycemia) Diabetes Mellitus.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 32 Diabetes Mellitus and the Metabolic Syndrome.
TREAT TO TARGET IN DIABETES: An Alternative pathway
Diabetes Mellitus Global and national prevalence of diabetes Global and national prevalence of diabetes Types of diabetes Types of diabetes Pathogenesis.
DIABETES AND HYPOGLYCEMIA. What is Diabetes Mellitus? “STARVATION IN A SEA OF PLENTY”
Diabetes Mellitus (Lecture 2). Type 2 DM 90% of diabetics (in USA) Develops gradually may be without obvious symptoms may be detected by routine screening.
Diabetes. Glucose n Required as fuel for cellular metabolism n Brain’s need for glucose parallels its demand for oxygen.
By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University By Hussam A.S. Murad.
WHY REGULATE PLASMA GLUCOSE? Set Point: mg/100 ml plasma Glucose is virtually the only fuel the brain can use to make ATP (also ketones) If plasma.
DIABETES MELLITUS By Prarit Arora
Complications Acute and Chronic. Complications  Acute: sudden onset usually reversible  Chronic: gradual onset can be irreversible.
Reem Sallam, MD, MSc. PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Dr. Amr S. Moustafa, MD, PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
DIABETES MELLITUS IN CHILDREN. Blood glucose Apart from transient illness-induced or stress-induced hyperglycemia, a random whole-blood glucose.
Hormonal regulation of glycaemia Alice Skoumalová.
Chronic elevation of blood glucose levels leads to the endothelium cells taking in more glucose than normal damaging the blood vessels. 2 types of damage.
Pathology and complications of Diabetes Mellitus.
Clinical Pathology B Case A Acute Diabetes The case history Mr CB, aged 40, has had type 1 diabetes since he was a child. He was brought in to the A &
Hormones and metabolism an overview
Overview of Carbohydrate Metabolism: The importance of regulating blood glucose levels.
Dr. Hany Ahmed Assistant Professor of Physiology (MD, PhD) Al Maarefa Colleges (KSA) & Zagazig University (EGY) Specialist of Diabetes, Metabolism and.
LABORATORY DIAGNOSTICS OF DIABETES MELLITUS. Epidemiology About 2 to 4 % of the world population is affected with DM The disease is more common: - in.
DIABETIC TEACHING VERMALYNPAULETTEMICHELLEEDWARD.
DIABETES MELLITUS Dr Heyam Awad FRCPath.
1- Blood glucose > 120 mg/dl (6.8 mmol/L) on two repeated measurements. Normal range for blood glucose mg/dl ( mmol/L). boarderline concentrations.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 50 Diabetes Mellitus and the Metabolic Syndrome.
Diabetes Mellitus Introduction to Diabetes Epidemiology.
LAB (6): LIPIDS PROFILE KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2013.
Diabetes mellitus.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
DM- ANSWERS TO CASES 1&2. ANSWERS 1. How did the insulin deficiency lead to an increase in plasma glucose & ketone conc.? Insulin is responsible for shifting.
Diabetes Mellitus Part 1 Kathy Martin DNP, RN, CNE.
Carbohydrates: Clinical applications Carbohydrate metabolism disorders include: Hyperglycemia: increased blood glucose Hypoglycemia: decreased blood glucose.
Pathophysiology Glucose Homeostasis & Diabetes Mellitus.
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
Diabetes mellitus.
III. Endocrine Pancreas Diabetes Mellitus
DIABETES MELLITUS DR HEYAM AWAD FRCPATH.
Practicals – experimental diabetes mellitus in laboratory animal
Metabolic Changes in Diabetes Mellitus
Multisystem.
Diabetes Mellitus Nursing Management.
Practicals – experimental diabetes mellitus in laboratory animal
Metabolic Changes in Diabetes Mellitus
Practicals – experimental diabetes mellitus in laboratory animal
Endocrine and Metabolic Systems
Metabolic Changes in Diabetes Mellitus
Pathology of endocrine pancreas
Presentation transcript:

Regarding type 1 diabetes mellitus, which one statement is correct: Regarding type 1 diabetes mellitus, which one statement is correct: a. Most commonly develops in old age b. Type 1 diabetes is an autoimmune disease with pancreatic beta islet cell destruction caused by T- lymphocytes c. Usually not associated with genetic susceptibility d. Type 1 diabetes is an autoimmune disease with pancreatic beta islet cell destruction caused by B- lymphocytes

Regarding type 1 diabetes mellitus, which one statement is correct: Regarding type 1 diabetes mellitus, which one statement is correct: a. Most commonly develops in old age b. Type 1 diabetes is an autoimmune disease with pancreatic beta islet cell destruction caused by T-lymphocytes c. Usually not associated with genetic susceptibility d. Type 1 diabetes is an autoimmune disease with pancreatic beta islet cell destruction caused by B- lymphocytes

Regarding type-2 diabetes mellitus (DM), which one statement is correct: Regarding type-2 diabetes mellitus (DM), which one statement is correct: a. Genetic factors less important than in type 1 DM b. There is no link between obesity and DM c. Insulin resistance is the primary event, followed by progressive pancreatic beta cell destruction d. Regulation of adipokines may lead to insulin resistance

Regarding type-2 diabetes mellitus (DM), which one statement is correct: Regarding type-2 diabetes mellitus (DM), which one statement is correct: a. Genetic factors less important than in type 1 DM b. There is no link between obesity and DM c. Insulin resistance is the primary event, followed by progressive pancreatic beta cell destruction d. Regulation of adipokines may lead to insulin resistance

Which one of these satisfy the diagnostic criteria for diabetes mellitus using fasting plasma glucose Which one of these satisfy the diagnostic criteria for diabetes mellitus using fasting plasma glucose a. 6.0 mmol/L b. 5.0 mmol/L c. 4.0 mmol/L d. 7.0 mmol/L

Which one of these satisfy the diagnostic criteria for diabetes mellitus using fasting plasma glucose levels (FPG): Which one of these satisfy the diagnostic criteria for diabetes mellitus using fasting plasma glucose levels (FPG): a. 6.0 mmol/L b. 5.0 mmol/L c. 4.0 mmol/L d. 7.0 mmol/L

Which one of these satisfy the diagnostic criteria for diabetes mellitus using two hour plasma glucose level using 75 gram oral glucose tolerance test (OGTT): Which one of these satisfy the diagnostic criteria for diabetes mellitus using two hour plasma glucose level using 75 gram oral glucose tolerance test (OGTT): a mmol/L b mmol/L c. 9.1 mmol/L d. 8.1 mmol/L

Which one of these satisfy the diagnostic criteria for diabetes mellitus using two hour plasma glucose level using 75 gram oral glucose tolerance test (OGTT): a mmol/L b mmol/L c. 9.1 mmol/L d. 8.1 mmol/L

Which one of these satisfy the diagnostic criteria for diabetes mellitus using random plasma glucose levels: Which one of these satisfy the diagnostic criteria for diabetes mellitus using random plasma glucose levels: a mmol/L b. 9.1 mmol/L c mmol/L d. 8.1 mmol/L

Which one of these satisfy the diagnostic criteria for diabetes mellitus using random plasma glucose levels: Which one of these satisfy the diagnostic criteria for diabetes mellitus using random plasma glucose levels: a mmol/L b. 9.1 mmol/L c mmol/L d. 8.1 mmol/L

Which one of these satisfy the diagnostic criteria for diabetes mellitus using blood glycosylated haemoglobin levels in percentages: a. HbA1c < 5.5 % b. HbA1c < 4.5 % c. HbA1c > 6.5 % d. HbA1c < 3.5 %

Which one of these satisfy the diagnostic criteria for diabetes mellitus using blood glycosylated haemoglobin levels in percentages: a. HbA1c < 5.5 % b. HbA1c < 4.5 % c. HbA1c > 6.5 % d. HbA1c < 3.5 %

Patients with each of the following conditions may manifest with elevated blood glucose levels except: Patients with each of the following conditions may manifest with elevated blood glucose levels except: a. Pheochromocytoma b. Cushing’s syndrome c. Glucagonoma d. Pancreatic beta cell neoplasms e. Elevated Growth hormone

Patients with each of the following conditions may manifest with elevated blood glucose levels except: Patients with each of the following conditions may manifest with elevated blood glucose levels except: a. Pheochromocytoma b. Cushing’s syndrome c. Glucagonoma d. Pancreatic beta cell neoplasms e. Elevated Growth hormone

Complication of diabetes mellitus (D.M) Brig Rizwan Hashim Pathology dept Army Medical College

Diabetes Mellitus vs Impaired Fasting Glucose/Impaired Glucose Tolerance DM – Risk of macrovascular and microvascular complications DM – Risk of macrovascular and microvascular complications IFG/IGT – Risk of macrovascular complications (But not microvascular) IFG/IGT – Risk of macrovascular complications (But not microvascular)

D.M Complications D.M Complications Short term Complications: (metabolic) Short term Complications: (metabolic) Hypoglycemia Hypoglycemia Diabetic Ketoacidosis Diabetic Ketoacidosis Non Ketotic hyperosmolar diabetic coma Non Ketotic hyperosmolar diabetic coma Lactic acidosis Lactic acidosis

Patho-physiology of DKA Relative or absolute insulin deficiency in the presence of catabolic counter-regulatory stress hormones (particularly glucagon and catecholamines, but also growth hormone and cortisol) leads to hepatic overproduction of glucose and ketones.

Patho-physiology of DKA Lack of insulin combined with excess stress hormones promotes lipolysis, with the release of non-esterified fatty acids (NEFA s ) from adipose tissue into the circulation. Lack of insulin combined with excess stress hormones promotes lipolysis, with the release of non-esterified fatty acids (NEFA s ) from adipose tissue into the circulation.

Mechanisms of ketoacidosis. NEFA, non-esterifies fatty acids.

Clinical features of diabetic ketoacidosis.

Complications Long term complications:(microangiopathy) Angiopathy, Angiopathy, Retinopathy, Retinopathy, Nephropathy, Nephropathy, Neuropathy Neuropathy

Long term Complications: Angiopathy Angiopathy Atherosclerosis Atherosclerosis Hyaline arteriolosclerosis Hyaline arteriolosclerosis Diabetic microangiopathy Diabetic microangiopathy Nephropathy Nephropathy Nodular glomerulosclerosis Nodular glomerulosclerosis Retinopathy Retinopathy Non Proliferative & Proliferative Non Proliferative & Proliferative Neuropathy Neuropathy Peripheral axonal neuropathy Peripheral axonal neuropathy

Pathogenesis of Microangiopathy: Long standing diabetes Long standing diabetes Combination of glucose with proteins - Particularly collagen in blood vessels - Glycosylation. Combination of glucose with proteins - Particularly collagen in blood vessels - Glycosylation. Excess deposition of glycosylated type IV collagen in the basement membrane Excess deposition of glycosylated type IV collagen in the basement membrane Thick and Leaky blood vessels. Thick and Leaky blood vessels. Chronic Ischemia & protein loss into tissues. Chronic Ischemia & protein loss into tissues. Organ damage... Organ damage...

Microvascular complications Proposed mechanisms Proposed mechanisms Hyperglycaemia- stimulates aldol reductase enzymes – metabolise glucose to sorbitol (polyol sugar) - tissue accumulation Hyperglycaemia- stimulates aldol reductase enzymes – metabolise glucose to sorbitol (polyol sugar) - tissue accumulation Non-enzymatic glycation of proteins (Amadori products, ‘ advanced glycation endproducts’) Non-enzymatic glycation of proteins (Amadori products, ‘ advanced glycation endproducts’)

C (CHOH) 4 | CH 2 OH NH || CH | (CHOH) 4 | CH 2 OH GlucoseProtein Schiff base H0 NH | CH 2 | C=O | (CHOH) 3 | (CH 2 OH) N N Protein cross- link in advanced glycosylation end products Amadori product NH 2 Reversible K1 K-1 (hours) K2 K-2 Reversible (days) KN Irreversible (Weeks) A

Ischemic Stage of Diabetic Retinopathy (low magnification) The microphotograph shows multiple capillary aneurysms

Pathogenesis of Retinopathy

Diabetic Eye Disease

Diabetic Retinopathy Cotton wool spots

New vessels on the iris (rubeosis iridis). There is also vitreous haemorrhage.

Diabetic cataract

Diabetic Nephropathy

Evolution of diabetic nephropathy

Diabetic Glomerulosclerosis

End-Stage Lesion of Diabetic Nephropathy The glomerulus in the center of the microphotograph is completely sclerotic. The most common cause of chronic renal failure in the United States is diabetic nephropathy.

Renal Tubules (high magnification) The basement membrane of the tubules are markedly thickened leading to tubular atrophy and dysfunction

Renal Necrotizing Papillitis Necrotizing papillitis is can occur in diabetics as a renal complication. The papilla extending into the minor calyces become necrotic as demonstrated in the microphotograph (arrows). Necrotizing papillitis can also be caused by sickle cell disease (vaso-occlusive) and indomethicin (toxicity).

Diabetic Neuropathy

Generalized wasting of the interossei (and hypothenar eminence) caused by bilateral ulnar nerve palsies in a diabetic patient.

Neuropathic foot, showing clawed toes, dry skin and prominent veins.

Typical neuropathy ulcer. Note the surrounding callus.

Distended veins on the dorsum of the foot of a diabetic patient with painful peripheral neuropathy.

Neuroischaemic damage caused by tightly fitting shoes.

Macro vascular Diseases in Diabetes

Diabetic Macrovascular DiseasePathophysiology Multiple metabolic changes Multiple metabolic changes Lipid changes in DM Lipid changes in DM - Raised total cholesterol, LDL and triglycerides - Raised total cholesterol, LDL and triglycerides - Low HDL - Low HDL LDL subfraction profile (small dense LDL) LDL subfraction profile (small dense LDL) Glycation and peroxidation of: Glycation and peroxidation of: - Lipoproteins - Lipoproteins - Thrombotic/thrombolytic factors - Thrombotic/thrombolytic factors

Lipid disorder in DM

Motility disorders associated with diabetes at various levels of the gastrointestinal tract.

Candidiasis

Other investigations: Serum Urea. Serum Creatinine Serum Lipid profile: cholesterol; triglyceride; LDL-C; HDL-C. Serum sodium, potassium, 24 hour urine for: protein; creatinine clearance; microalbumin; Spot urine for microalbumin Spot urine for albumin creatinine ratio- ACR

Other investigations and evaluations: Blood complete picture Urine routine examination: glucose; protein/, albumin, WBC, sp gravity. Urine for ketone bodies Arterial blood gases-ABG’s Ultra sound liver- Fatty liver Fundoscopy- for diabetic retinopathy; Routine eye exam: diabetic cataract Blood pressure measurement Examination of feet- ulcer; poor sensations/neuropathy

Insulin pens Management

Monitoring

Metabolic abnormalities leading to Microvascular complications in DM

Figure 18.4

Flowchart for the investigation of diabetic ketoacidosis

The stages and determinants of diabetic nephropathy.(AER, albumin excretion rate.) Diabetic nephropathy